A Study to Assess the Food Effect and the Relative Bioavailability of the Cabotegravir (CAB) Pediatric Dispersible Tablet (DT) Formulation
Clinical trial NCT05776108 · COMPLETED
Trial details
- NCT number
- NCT05776108
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2023-06-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.